SWK Holdings CorpSWKH

Market cap

$215.18M

P/E ratio

	Dec 31, 2011	Dec 31, 2012	Dec 31, 2013	Dec 31, 2014	Dec 31, 2015	Dec 31, 2016	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022
Finance receivable interest income, including fees	-	-	3	12	17	16	27	26	30	31	39	35
Pharmaceutical development	-	-	-	-	-	-	-	-	1	6	16	5
Other	-	-	-	-	-	-	-	-	0	0	1	1
Total revenues	-	1	6	17	23	22	37	26	31	37	56	41
Provision for credit losses	-	-	-	-	11	-	-	-	-	-	-	3
Interest expense	-	-	-	-	0	-	-	0	0	0	0	0
Pharmaceutical manufacturing, research and development expense	-	-	-	-	-	-	-	-	1	4	7	7
General and administrative	2	2	2	3	3	3	4	5	7	11	14	13
Change in fair value of acquisition-related contingent consideration	-	-	-	-	-	-	-	-	-	4	-0	5
Depreciation and amortization expense	-	-	-	0	0	-	-	-	5	12	4	3
Income from operations	2	2	2	3	21	13	13	19	16	32	25	-10
Unrealized net gain on warrants	-	-	-	-	-3	1	-1	0	0	-1	0	0
Unrealized net (loss) gain on equity securities	-	-	-	-	-	-	-	-1	2	-1	2	-1
Realized loss on sale of investments	-	-	-	-	-	-	0	-0	0	0	-0	-0
Foreign currency transaction loss	-	-	-	-	-	-	-	-	-	-	-	-0
Income before income tax (benefit) expense	-1	-1	4	13	-1	10	24	6	17	4	33	9
Income tax (benefit) expense	-0	-0	-10	-10	3	-	16	0	-7	-2	7	-4
Net income	-	-1	14	24	-4	32	8	6	24	5	26	13
Basic	-	-	0.31	0.32	-0.57	2.22	0.23	0.47	1.85	0.4	2.03	1.05
Diluted	-	-	0.31	0.32	-0.57	2.22	0.23	0.47	1.85	0.4	2.02	1.05